These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29386497)

  • 1. [A case of acute leukoencephalopathy induced by a combination of 5-fluorouracil and metronidazole].
    Fukumoto T; Katada F; Sato S; Shibayama H; Murayama S; Fukutake T
    Rinsho Shinkeigaku; 2018 Feb; 58(2):118-123. PubMed ID: 29386497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion weighted MR imaging of 5-fluorouracil and oxaliplatin-induced leukoencephalopathy.
    Paul BS; Singh G; Bansal R; Paul G
    J Postgrad Med; 2013; 59(2):135-7. PubMed ID: 23793316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Late-onset leukoencephalopathy induced by long-term chemotherapy with capecitabine and cyclophosphamide for liver metastasis from breast cancer].
    Yasaki S; Tukamoto Y; Yuasa N; Ishikawa T; Yoshii F
    Rinsho Shinkeigaku; 2012; 52(4):251-6. PubMed ID: 22531658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible leukoencephalopathy with stroke-like presentation in a patient with 5-dihydropyrimidine dehydrogenase deficiency treated with continuous 5-fluorouracil infusion.
    Li J; Lee JJ; Chu E; Baehring JM
    Clin Colorectal Cancer; 2012 Sep; 11(3):215-7. PubMed ID: 22410472
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
    Delaunoit T; Goldberg RM; Sargent DJ; Morton RF; Fuchs CS; Findlay BP; Thomas SP; Salim M; Schaefer PL; Stella PJ; Green E; Mailliard JA
    Cancer; 2004 Nov; 101(10):2170-6. PubMed ID: 15470715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI.
    Akitake R; Miyamoto S; Nakamura F; Horimatsu T; Ezoe Y; Muto M; Chiba T
    Jpn J Clin Oncol; 2011 Jan; 41(1):121-4. PubMed ID: 20926409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
    André T; Bensmaine MA; Louvet C; François E; Lucas V; Desseigne F; Beerblock K; Bouché O; Carola E; Merrouche Y; Morvan F; Dupont-André G; de Gramont A
    J Clin Oncol; 1999 Nov; 17(11):3560-8. PubMed ID: 10550155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pain associated with oxaliplatin infusion: case report and literature review.
    Clay TD; Ashley DA
    J Oncol Pharm Pract; 2012 Dec; 18(4):421-4. PubMed ID: 22080592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
    J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
    Hwang JJ
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [pericarditis following 5-fluorouracil administration].
    Maréchal S; Racaru V; Houbiers G; Graas MP
    Rev Med Liege; 2015; 70(7-8):360-6. PubMed ID: 26376561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.
    Freyer G; Bossard N; Romestaing P; Mornex F; Chapet O; Trillet-Lenoir V; Gérard JP
    J Clin Oncol; 2001 May; 19(9):2433-8. PubMed ID: 11331322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
    Twelves C
    Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
    Al-Batran SE; Kerber A; Atmaca A; Dechow C; Reitsamer E; Schmidt S; Kolassa Y; Neumann A; Weidmann E; Hartmann JT; Jäger E
    Onkologie; 2007 Feb; 30(1-2):29-34. PubMed ID: 17264523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy.
    Sundar S; Symonds RP; Decatris MP; Kumar DM; Osman A; Vasanthan S; O'byrne KJ
    Gynecol Oncol; 2004 Aug; 94(2):502-8. PubMed ID: 15297195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early diagnosis of capecitabine-induced acute leukoencephalopathy by using diffusion-weighted MRI].
    Shimoyama R; Ban T; Miyake K; Isogai N; Ikegaya Y; Kawachi J; Ogino H; Watanabe K
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1251-3. PubMed ID: 25335709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of mFOLFOX6-induced lactic acidosis in a patient with colon cancer].
    Ito A; Kawamoto K; Park T; Ito T
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1445-7. PubMed ID: 25434453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.